You are here

Endocrinologie

Diabetes type 1

Effect of semaglutide versus placebo on the progression of renal impairmant in subjects with type 2 diabetes and chronic kidney disease. (Flow)

Diabetes type 2

The Effect of Tirzepatide versus Dulaglutide on Major Adverse Cardiovascular Events in Patients with Type 2 Diabetes (SURPASS-CVOT)

 

Contact studieteam
e  ctc.onco@azdelta.be
Rina Talpe t  051 23 75 11 
Els Verbruggen t 051 23 39 04 
Nathalie Van Damme t 051 23 73 25